Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ray
W N Andrews

Showing results (61-70 of 232) with videos related to

Pageof 24
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2020
Reduced risk of second primary cancer in patients treated with immune checkpoint inhibitors for a first cancerP Heudel, S Chabaud, D Perol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2021
Checkpoint inhibition: protecting against or predisposing for second primary tumors? Reply to the Letter to the Editor 'Checkpoint inhibition: protecting against or predisposing for second primary tumors?' by K. P. M. Suijkerbuijk, A. M. May and M. J. M. van EijsP Heudel, S Chabaud, D Perol, et al.
Neurochemical Research|July 1, 1997
Metal cations defibrillize the amyloid beta-protein fibrilsV P Chauhan, I Ray, A Chauhan, et al.
Bulletin Du Cancer|May 26, 2010
[Targeted treatment of rare connective tissue tumors and sarcomas]P Cassier, D Pissaloux, L Alberti, et al.
QJM : Monthly Journal of the Association of Physicians|March 3, 2022
Myocarditis post-SARS-CoV-2 vaccination: a systematic reviewM Goyal, I Ray, D Mascarenhas, et al.
QJM : Monthly Journal of the Association of Physicians|March 15, 2022
Response to: Caution with the use of NSAIDs in myocarditisM Goyal, I Ray, D Mascarenhas, et al.
Journal of the American College of Surgeons|March 1, 1997
Combined percutaneous transluminal angioplasty, iliac stent deployment, and femorofemoral bypass for bilateral aortoiliac occlusive diseaseL A Lopez-Galarza, L I Ray, J Rodriguez-Lopez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2008
Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT)J-Y Blay, H El Sayadi, P Thiesse, et al.
JAMA|November 25, 1997
Impact of a clinical guidelines program for breast and colon cancer in a French cancer centerI Ray-Coquard, T Philip, M Lehmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2021
PARP inhibitors and newly second primary malignancies in cancer patients: a systematic review and safety meta-analysis of placebo randomized controlled trialsP-M Morice, I Ray-Coquard, K N Moore, et al.
Pageof 24

Showing results (61-70 of 232) with videos related to

Sort By:
Pageof 24
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2020
Reduced risk of second primary cancer in patients treated with immune checkpoint inhibitors for a first cancerP Heudel, S Chabaud, D Perol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2021
Checkpoint inhibition: protecting against or predisposing for second primary tumors? Reply to the Letter to the Editor 'Checkpoint inhibition: protecting against or predisposing for second primary tumors?' by K. P. M. Suijkerbuijk, A. M. May and M. J. M. van EijsP Heudel, S Chabaud, D Perol, et al.
Neurochemical Research|July 1, 1997
Metal cations defibrillize the amyloid beta-protein fibrilsV P Chauhan, I Ray, A Chauhan, et al.
Bulletin Du Cancer|May 26, 2010
[Targeted treatment of rare connective tissue tumors and sarcomas]P Cassier, D Pissaloux, L Alberti, et al.
QJM : Monthly Journal of the Association of Physicians|March 3, 2022
Myocarditis post-SARS-CoV-2 vaccination: a systematic reviewM Goyal, I Ray, D Mascarenhas, et al.
QJM : Monthly Journal of the Association of Physicians|March 15, 2022
Response to: Caution with the use of NSAIDs in myocarditisM Goyal, I Ray, D Mascarenhas, et al.
Journal of the American College of Surgeons|March 1, 1997
Combined percutaneous transluminal angioplasty, iliac stent deployment, and femorofemoral bypass for bilateral aortoiliac occlusive diseaseL A Lopez-Galarza, L I Ray, J Rodriguez-Lopez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2008
Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT)J-Y Blay, H El Sayadi, P Thiesse, et al.
JAMA|November 25, 1997
Impact of a clinical guidelines program for breast and colon cancer in a French cancer centerI Ray-Coquard, T Philip, M Lehmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2021
PARP inhibitors and newly second primary malignancies in cancer patients: a systematic review and safety meta-analysis of placebo randomized controlled trialsP-M Morice, I Ray-Coquard, K N Moore, et al.
Pageof 24